Mercury emission from a temperate lake during autumn turnover

Lakes in temperate regions stratify during summer and winter months, creating distinct Positive correlations between dissolved mercury and iron and manganese also suggest a role for these elements in mercury transport within the lake, but iron and manganese did not demonstrate a relationship with emission rates. This research indicates that consideration of seasonal processes in lakes is important when evaluating mercury cycling in aquatic systems. © 2009 Elsevier B.V. All rights reserved. Keywords: Mercury emission Lake turnover Dynamic flux chamber Introduction Mercury in aquatic systems bioaccumulates in the food web and has toxic effects at all trophic levels. The reduction of dissolved Hg(II) to Hg 0 often results in partitioning of mercury from terrestrial or aquatic surfaces to the atmosphere where J Hg is the calculated mercury flux, Q is the air sampling flow rate, A is the water surface area within the chamber, an

Human Vault Nanoparticle Targeted Delivery of Antiretroviral Drugs to Inhibit Human Immunodeficiency Virus Type 1 Infection.

"Vaults" are ubiquitously expressed endogenous ribonucleoprotein nanoparticles with potential utility for targeted drug delivery. Here, we show that recombinant human vault nanoparticles are readily engulfed by certain key human peripheral blood mononuclear cells (PBMC), predominately dendritic cells, monocytes/macrophages, and activated T cells. As these cell types are the primary targets for human immunodeficiency virus type 1 (HIV-1) infection, we examined the utility of recombinant human vaults for targeted delivery of antiretroviral drugs. We chemically modified three different antiretroviral drugs, zidovudine, tenofovir, and elvitegravir, for direct conjugation to vaults. Tested in infection assays, drug-conjugated vaults inhibited HIV-1 infection of PBMC with equivalent activity to free drugs, indicating vault delivery and drug release in the cytoplasm of HIV-1-susceptible cells. The ability to deliver functional drugs via vault nanoparticle conjugates suggests their potential utility for targeted drug delivery against HIV-1